United Therapeutics (UTHR) News Today $394.62 -5.90 (-1.47%) Closing price 09/8/2025 04:00 PM EasternExtended Trading$391.26 -3.36 (-0.85%) As of 09/8/2025 06:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock UTHR Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period FY2027 EPS Estimate for United Therapeutics Cut by Analyst1 hour ago | americanbankingnews.comResearch Analysts Offer Predictions for UTHR FY2027 Earnings48 minutes ago | marketbeat.comUnited Therapeutics Shows Market Leadership With Jump To 81 RS RatingSeptember 8 at 12:47 PM | msn.comUnited Therapeutics Gets A Composite Rating UpgradeSeptember 8 at 12:47 PM | msn.comParkman Healthcare Partners LLC Decreases Stake in United Therapeutics Corporation $UTHRSeptember 8 at 7:45 AM | marketbeat.comAmundi Buys 232,988 Shares of United Therapeutics Corporation $UTHRSeptember 8 at 5:13 AM | marketbeat.comFederation des caisses Desjardins du Quebec Raises Holdings in United Therapeutics Corporation $UTHRSeptember 8 at 4:57 AM | marketbeat.comShort Interest in United Therapeutics Corporation (NASDAQ:UTHR) Increases By 82.2%September 8 at 4:15 AM | marketbeat.comUnited Therapeutics Corporation (NASDAQ:UTHR) Receives Consensus Recommendation of "Moderate Buy" from AnalystsSeptember 8 at 2:38 AM | marketbeat.comUnited Therapeutics (NASDAQ:UTHR) Price Target Raised to $500.00September 8 at 2:47 AM | americanbankingnews.comWayfair, United Therapeutics, And Ciena Are Among The Top 10 Large-Cap Gainers Last Week (July 14-July 18): Are The Others In Your Portfolio?September 7 at 10:51 AM | benzinga.comUnited Therapeutics (NASDAQ:UTHR) Stock Price Expected to Rise, HC Wainwright Analyst SaysSeptember 7 at 8:13 AM | marketbeat.comNitorum Capital L.P. Sells 17,373 Shares of United Therapeutics Corporation $UTHRSeptember 7 at 7:26 AM | marketbeat.comOppenheimer Sticks to Their Buy Rating for United Therapeutics (UTHR)September 7 at 6:33 AM | theglobeandmail.comGotham Asset Management LLC Purchases 28,163 Shares of United Therapeutics Corporation $UTHRSeptember 7 at 6:20 AM | marketbeat.comHancock Whitney Corp Lowers Holdings in United Therapeutics Corporation $UTHRSeptember 7 at 6:19 AM | marketbeat.comUnited Therapeutics Corporation $UTHR Shares Sold by Clark Capital Management Group Inc.September 7 at 5:56 AM | marketbeat.comAlliancebernstein L.P. Has $140.26 Million Stock Position in United Therapeutics Corporation $UTHRSeptember 7 at 5:36 AM | marketbeat.comUnited Therapeutics (NASDAQ:UTHR) Price Target Raised to $575.00 at OppenheimerSeptember 7 at 2:17 AM | americanbankingnews.comAnalysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR) and Sanofi (OtherSNYNF)September 6 at 10:30 AM | theglobeandmail.comInsider Selling: United Therapeutics (NASDAQ:UTHR) COO Sells 22,500 Shares of StockSeptember 6 at 9:38 AM | marketbeat.comUnited Therapeutics Corporation $UTHR Shares Sold by Eventide Asset Management LLCSeptember 6 at 8:44 AM | marketbeat.comInsider Selling: United Therapeutics (NASDAQ:UTHR) EVP Sells 11,000 Shares of StockSeptember 6 at 7:40 AM | insidertrades.comBanque Transatlantique SA Takes Position in United Therapeutics Corporation $UTHRSeptember 6 at 7:16 AM | marketbeat.comTrexquant Investment LP Takes $2.75 Million Position in United Therapeutics Corporation $UTHRSeptember 6 at 4:43 AM | marketbeat.comUnited Therapeutics price target raised to $575 from $510 at OppenheimerSeptember 5, 2025 | msn.comUnited Therapeutics (NASDAQ:UTHR) Trading Down 4.8% Following Insider SellingSeptember 5, 2025 | marketbeat.comWells Fargo & Company Forecasts Strong Price Appreciation for United Therapeutics (NASDAQ:UTHR) StockSeptember 5, 2025 | marketbeat.comAQR Capital Management LLC Has $273.31 Million Stake in United Therapeutics Corporation $UTHRSeptember 5, 2025 | marketbeat.comUnited Therapeutics (NASDAQ:UTHR) COO Sells $9,396,900.00 in StockSeptember 5, 2025 | insidertrades.comThe Manufacturers Life Insurance Company Has $22.12 Million Stake in United Therapeutics Corporation $UTHRSeptember 5, 2025 | marketbeat.comUnited Therapeutics (NASDAQ:UTHR) Given New $414.00 Price Target at Wells Fargo & CompanySeptember 5, 2025 | americanbankingnews.comUnited Therapeutics price target raised to $560 from $415 at UBSSeptember 5, 2025 | msn.comUnited Therapeutics (NASDAQ:UTHR) Shares Down 4.8% Following Insider SellingSeptember 5, 2025 | americanbankingnews.comInsider Selling: United Therapeutics (NASDAQ:UTHR) Director Sells 3,000 Shares of StockSeptember 4, 2025 | marketbeat.comUnited Therapeutics: Nebulized Tyvaso Label Expansion Possible For IPF After Study WinSeptember 4, 2025 | seekingalpha.comUnited Therapeutics (NASDAQ:UTHR) Given New $564.00 Price Target at Jefferies Financial GroupSeptember 4, 2025 | marketbeat.comBiotech Stocks To Consider - September 2ndSeptember 4, 2025 | marketbeat.comUnited Therapeutics (NASDAQ:UTHR) Given New $463.00 Price Target at Bank of AmericaSeptember 4, 2025 | marketbeat.comUnited Therapeutics (NASDAQ:UTHR) Reaches New 52-Week High - Here's WhySeptember 4, 2025 | marketbeat.comBirchview Capital LP Sells 2,500 Shares of United Therapeutics Corporation $UTHRSeptember 4, 2025 | marketbeat.comUnited Therapeutics Corporation $UTHR Shares Purchased by MPM Bioimpact LLCSeptember 4, 2025 | marketbeat.comPalo Alto Investors LP Sells 50,486 Shares of United Therapeutics Corporation $UTHRSeptember 4, 2025 | marketbeat.comUnited Therapeutics Corporation $UTHR Shares Bought by Panagora Asset Management Inc.September 4, 2025 | marketbeat.comBank of America Forecasts Strong Price Appreciation for United Therapeutics (NASDAQ:UTHR) StockSeptember 4, 2025 | americanbankingnews.comBuy Rating for United Therapeutics: Promising TETON-2 Trial Results Highlight Tyvaso’s Potential in IPF TreatmentSeptember 4, 2025 | tipranks.comUnited Therapeutics Earns Membership In 95-Plus Composite Rating ClubSeptember 3, 2025 | msn.comUnited Therapeutics Stock (UTHR) Opinions on Positive Tyvaso Trial ResultsSeptember 3, 2025 | quiverquant.comQUnited Therapeutics rises 42.1%September 3, 2025 | msn.comUnited Therapeutics price target raised to $564 from $432 at JefferiesSeptember 3, 2025 | msn.com Get United Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for UTHR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. UTHR Media Mentions By Week UTHR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. UTHR News Sentiment▼1.020.72▲Average Medical News Sentiment UTHR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. UTHR Articles This Week▼7621▲UTHR Articles Average Week Get the Latest News and Ratings for UTHR and Related Stocks Enter your email address to receive the latest news and analysts' ratings for United Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies BIIB News INCY News NBIX News BMRN News EXEL News MDGL News EXAS News HALO News RGEN News IONS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:UTHR) was last updated on 9/9/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredBuffett, Gates and Bezos Dumping StocksThe world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated b...Banyan Hill Publishing | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding United Therapeutics Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share United Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free UTHR Stock Alerts